Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Hematoma Block as an Adjunct to Procedural Sedation for Forearm Fracture Reduction

This study has been terminated.
(Recruitment was taking longer than originally anticipated.)
Information provided by (Responsible Party):
Erika Constantine, Rhode Island Hospital Identifier:
First received: September 26, 2008
Last updated: November 18, 2013
Last verified: November 2013
The purpose of our study is to determine if the use of a hematoma block together with intravenous sedation and analgesia is an effective means of managing forearm fractures in the Emergency Department. To determine this, we have designed a randomized, double-blind, placebo controlled trial of hematoma block versus saline for the manipulation of forearm fractures under conscious sedation with ketamine and midazolam. Our hypotheses are two-fold: First, the use of a hematoma block together with conscious sedation will allow for improved pain control. Second, the use of a hematoma block together with conscious sedation will allow us to use less sedation, therefore promoting faster recovery from sedation and more efficient patient turnover in the Emergency Department.

Condition Intervention Phase
Forearm Fracture
Drug: Lidocaine
Drug: Saline
Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Double Blind (Participant, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Hematoma Blocks in Forearm Fractures: An Effective Adjunct to Procedural Sedation?

Resource links provided by NLM:

Further study details as provided by Rhode Island Hospital:

Primary Outcome Measures:
  • Total sedation time [ Time Frame: Evaluated upon completion of procedure ]

Secondary Outcome Measures:
  • Non-union [ Time Frame: 1 month ]
  • Need for re-manipulation [ Time Frame: 1 week ]
  • Adverse effects of sedation [ Time Frame: For the duration of the procedure ]
  • Adverse effects of hematoma block [ Time Frame: 1 month ]
  • Pain control [ Time Frame: For entire duration of procedure ]

Enrollment: 89
Study Start Date: November 2005
Study Completion Date: September 2008
Primary Completion Date: September 2008 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Lidocaine
Subjects randomly assigned to this arm will receive 2% lidocaine by injection into their fracture site in the form of a hematoma block.
Drug: Lidocaine
2% Lidocaine (no epinephrine) in the dose of 2.5 mg/kg to a maximum of 10mL will be instilled once into the fracture site in the form of a hematoma block.
Other Names:
  • Xylocaine
  • Lidocaine hydrochloride
Placebo Comparator: Normal Saline
Subjects randomly assigned to this arm will receive normal saline by injection into their fracture site
Drug: Saline
Volume of normal saline equivalent to providing 2.5mg/kg of 2% lidocaine, to a maximum of 10mL.
Other Name: Sodium Chloride


Ages Eligible for Study:   3 Years to 17 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • English or Spanish speaking
  • Ages 3-17
  • Closed distal forearm fracture requiring reduction under sedation in the Emergency Department
  • Fracture involves the distal third of the forearm

Exclusion Criteria:

  • Multiple trauma victims
  • Associated nerve or vascular damage
  • Associated elbow or humerus injury
  • Sensitivity or allergy to lidocaine
  • Contraindications to procedural sedation
  • Previous attempts at reduction for the same injury
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00763880

United States, Rhode Island
Hasbro Children's Hospital/Rhode Island Hospital
Providence, Rhode Island, United States, 02903
Sponsors and Collaborators
Rhode Island Hospital
Principal Investigator: Erika Constantine, MD Rhode Island Hospital
  More Information

Responsible Party: Erika Constantine, Clinical Assistant Professor, Rhode Island Hospital Identifier: NCT00763880     History of Changes
Other Study ID Numbers: CMTT # 4040-05
Study First Received: September 26, 2008
Last Updated: November 18, 2013

Keywords provided by Rhode Island Hospital:
Hematoma block
Forearm fracture
Radius fracture
Ulna fracture
Procedural sedation

Additional relevant MeSH terms:
Fractures, Bone
Wounds and Injuries
Pathologic Processes
Anesthetics, Local
Central Nervous System Depressants
Physiological Effects of Drugs
Sensory System Agents
Peripheral Nervous System Agents
Anti-Arrhythmia Agents
Voltage-Gated Sodium Channel Blockers
Sodium Channel Blockers
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action processed this record on May 24, 2017